Breaking News Instant updates and real-time market news.

R

Ryder

$68.36

0.05 (0.07%)

04:55
05/16/18
05/16
04:55
05/16/18
04:55

Ryder management to meet with Seaport Global

Meetings to be held in Canada May 15-16 hosted by Seaport Global.

  • 16

    May

  • 07

    Jun

R Ryder
$68.36

0.05 (0.07%)

04/05/18
JPMS
04/05/18
DOWNGRADE
Target $65
JPMS
Underweight
Ryder downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Brian Ossenbeck downgraded Ryder System to Underweight and cut his price target for the shares to $65 from $73. The analyst is making a "longer term call on 2019 expectations," which he believes are too high and embed "significant gains on residual values and used truck sales." Into the Q1 earnings season, the analyst is more cautious on the Class I rails and intermodal providers as "rail service levels remain anemic."
04/05/18
04/05/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Hold from Buy at Stifel with analyst Kevin Cassidy citing the peaking server central processing unit cycle and valuation for the downgrade. 2. Johnson Controls (JCI) downgraded to Underperform from Sector Perform at RBC Capital with analyst Deane Dray citing the company's exposure to additional cash flow pressures in fiscal 2018, reduction in fiscal 2020 targets, and a market rotation toward "more defensive names." 3. Ryder (R) downgraded to Underweight from Neutral at JPMorgan with analyst Brian Ossenbeck saying he is making a "longer term call on 2019 expectations," which he believes are too high and embed "significant gains on residual values and used truck sales." 4. Ollie's Bargain Outlet (OLLI) downgraded to Neutral from Buy at BofA/Merrill with analyst Elizabeth Suzuki saying valuation is getting "richer," quarterly comps have been decelerating since 2015, and are now expected to be 1%-2% in 2018. 5. Biogen (BIIB), Pfizer (PFE), Biohaven (BHVN), and Myovant Sciences (MYOV) were downgraded to Equal Weight from Overweight at Barclays. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/10/18
GSCO
04/10/18
INITIATION
Target $73
GSCO
Neutral
Ryder initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Matt Reustle started Ryder with a Neutral rating and $73 price target. The analyst wants to see more evidence of a used truck market recovery being getting more constructive on the shares. Reustle this morning initiated the Truck sector with a Neutral coverage view, saying it is "too early to fade the trucking cycle."
05/02/18
DBAB
05/02/18
NO CHANGE
Target $133
DBAB
Buy
Deutsche sees last mile competition having 'muted' impact on XPO
Deutsche Bank analyst Amit Mehrotra highlights a Reuters report saying UPS (UPS) and Werner Enterprises (WERN) are in in talks to partner on a new in-home delivery service for bulk goods. This development follows Ryder's (R) acquisition last month of MXD Group, Mehrotra tells investors in an intraday research note. The analyst sees implications for XPO, noting the company's last mile delivery of heavy goods is one of its fastest growing businesses. Despite the headline risks, fundamental implications for XPO are likely "muted," Mehrotra contends. He believes XPO has built a competitive advantage around its owned service center model and sees the heavy goods last mile market, estimated at $13B per annum and growing at 10%-15%, as allowing for more entrants without much impact to existing players. XPO in morning trading is down 2% to $93.89. Mehrotra has a Buy rating on the shares with a $133 price target.

TODAY'S FREE FLY STORIES

NKTR

Nektar

$82.81

0.87 (1.06%)

, BMY

Bristol-Myers

$52.49

0.14 (0.27%)

05:36
05/24/18
05/24
05:36
05/24/18
05:36
Recommendations
Nektar, Bristol-Myers, Merck analyst commentary  »

Nektar is…

NKTR

Nektar

$82.81

0.87 (1.06%)

BMY

Bristol-Myers

$52.49

0.14 (0.27%)

MRK

Merck

$59.16

0.7 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 02

    Jun

  • 05

    Jun

  • 12

    Jun

  • 10

    Jul

  • 10

    Sep

  • 23

    Oct

ABBV

AbbVie

$105.60

-0.72 (-0.68%)

05:34
05/24/18
05/24
05:34
05/24/18
05:34
Downgrade
AbbVie rating change  »

AbbVie downgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 05

    Jun

GBNK

Guaranty Bancorp

$33.05

0.6 (1.85%)

, IBTX

Independent Bank

$74.20

-3.65 (-4.69%)

05:29
05/24/18
05/24
05:29
05/24/18
05:29
Downgrade
Guaranty Bancorp, Independent Bank rating change  »

Guaranty Bancorp…

GBNK

Guaranty Bancorp

$33.05

0.6 (1.85%)

IBTX

Independent Bank

$74.20

-3.65 (-4.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

EC

Ecopetrol

$21.15

-0.62 (-2.85%)

05:28
05/24/18
05/24
05:28
05/24/18
05:28
Upgrade
Ecopetrol rating change  »

Ecopetrol upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRML

Vermillion

$1.05

0.045 (4.48%)

05:27
05/24/18
05/24
05:27
05/24/18
05:27
Downgrade
Vermillion rating change  »

Vermillion downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZR

Caesars

$12.50

-0.15 (-1.19%)

05:26
05/24/18
05/24
05:26
05/24/18
05:26
Initiation
Caesars initiated  »

Caesars initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLNT

Melinta Therapeutics

$6.25

-0.2 (-3.10%)

05:26
05/24/18
05/24
05:26
05/24/18
05:26
Syndicate
Melinta Therapeutics 22M share Secondary priced at $5.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

TDY

Teledyne

$198.96

2.19 (1.11%)

05:24
05/24/18
05/24
05:24
05/24/18
05:24
Hot Stocks
Teledyne awarded second phase of $47M contract from ESA »

The European Space…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOG

Northern Oil and Gas

$2.69

0.06 (2.28%)

05:22
05/24/18
05/24
05:22
05/24/18
05:22
Upgrade
Northern Oil and Gas rating change  »

Northern Oil and Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDC

Rowan Companies

05:22
05/24/18
05/24
05:22
05/24/18
05:22
Upgrade
Rowan Companies rating change  »

Rowan Companies upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OI

Owens-Illinois

$18.85

-0.1 (-0.53%)

05:21
05/24/18
05/24
05:21
05/24/18
05:21
Upgrade
Owens-Illinois rating change  »

Owens-Illinois upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$156.59

1.52 (0.98%)

05:21
05/24/18
05/24
05:21
05/24/18
05:21
Upgrade
Deere rating change  »

Deere upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNRC

Generac

$50.56

0.42 (0.84%)

05:21
05/24/18
05/24
05:21
05/24/18
05:21
Downgrade
Generac rating change  »

Generac downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

PBR

Petrobras

$15.10

-0.6 (-3.82%)

05:19
05/24/18
05/24
05:19
05/24/18
05:19
Downgrade
Petrobras rating change  »

Petrobras downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$15.10

-0.6 (-3.82%)

05:19
05/24/18
05/24
05:19
05/24/18
05:19
Downgrade
Petrobras rating change  »

Petrobras downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$76.38

-0.465 (-0.61%)

05:19
05/24/18
05/24
05:19
05/24/18
05:19
Hot Stocks
Sandoz receives European Commission approval for Zessly »

Sandoz, a Novartis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

ARCT

Arcturus Therapeutics

$6.66

-0.29 (-4.17%)

05:17
05/24/18
05/24
05:17
05/24/18
05:17
Hot Stocks
Arcturus Therapeutics comments on court ruling on former CEO 13D situation »

Arcturus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

MTDR

Matador

$31.07

-0.735 (-2.31%)

05:14
05/24/18
05/24
05:14
05/24/18
05:14
Recommendations
Matador analyst commentary  »

Matador 'geared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESYJY

easyJet

$0.00

(0.00%)

05:08
05/24/18
05/24
05:08
05/24/18
05:08
Downgrade
easyJet rating change  »

easyJet downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRMW

Primo Water

$15.48

0.56 (3.75%)

05:05
05/24/18
05/24
05:05
05/24/18
05:05
Initiation
Primo Water initiated  »

Primo Water initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGN

Align Technology

$308.24

10.26 (3.44%)

05:04
05/24/18
05/24
05:04
05/24/18
05:04
Recommendations
Align Technology analyst commentary  »

Align Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

CDNA

CareDx

$11.66

-0.12 (-1.02%)

04:55
05/24/18
05/24
04:55
05/24/18
04:55
Conference/Events
CareDx management to meet with Craig Hallum »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 29

    May

04:55
05/24/18
05/24
04:55
05/24/18
04:55
General news
Breaking General news story  »

Philadelphia Federal…

04:55
05/24/18
05/24
04:55
05/24/18
04:55
General news
Breaking General news story  »

3-Month Bill Announcement…

04:55
05/24/18
05/24
04:55
05/24/18
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.